Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2019 | Pages:
111 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 8.1% over the estimated time period. Rise in disease incidence coupled with growing demand for novel diagnosis products are thrusting the growth of the market. Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer in adults. It is among the common causes of death in people with liver cirrhosis and the third-leading cause of cancer deaths across the globe. Poor survival rate and lack of therapies has made this disease a crucial health issue worldwide. Government and some global health organizations are undertaking initiatives to raise awareness regarding liver cancer through various campaigns. These programs aim to create awareness about signs, symptoms, and complications associated with carcinomas. High costs associated with cancer treatments compared to other diseases have led to increasingly rigid treatment guidelines for expensive drugs and diagnostic tests across various markets. For instance, the Affordable Care Act, designed to improve quality of healthcare and reduce the cost associated with it. This act covers reimbursement for cancer diagnosis and treatment up to a certain extent. Governments in other countries are also taking efforts to overcome challenges, such as cost and access to cancer care. Such efforts and insurance policies that cover cost of diagnosis and treatment of carcinomas are supporting market growth. Newer techniques developed for hepatocellular carcinoma render both liver transplant, as well as surgical resection, more effective and safer. Several etiological factors of HCC such as hepatitis infection and cirrhosis are modifiable and thus present a strong prospect to reduce disease mortality by preventive strategies. Key players and medical institutions are focusing on the development of advanced tests for HCC diagnosis. These factors along with high unmet needs are expected to propel the growth of liver cancer diagnostics market through the forecast period. Further key findings from the study suggest: • Increasing awareness about liver cancer across the globe is expected to be the major factor driving the market growth • Laboratory tests emerged as the largest segment owing to increased demand for effective diagnostic tests for HCC • Oncofetal and Glucoprotein antigens accounted for the largest share in biomarkers segment • North America led the global liver cancer diagnostic market in 2017 and will maintain the dominance in future on account of rising awareness about early diagnosis and demand for novel diagnostic tests in the region • Illumina, Inc.; Qiagen; F. Hoffmann-La Roche Ltd.; Siemens Healthcare GmbH; and Thermo Fisher Scientific are some of the leading industry participants
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Research Scope and Assumptions
1.4 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Industry Outlook
4.1 Market Variable Analysis
4.1.1 Failure rate of conventional diagnosis
4.1.2 Early detection leading to reduced healthcare costs
4.2 Market Restraint Analysis
4.2.1 High risk of radiation exposure and stringent regulatory guidlines
4.2.2 High cost and unmet needs
Chapter 5 Business Environment Analysis
5.1 SWOT Analysis; by factor (political & legal, economic and technological)
5.2 Porter's five forces analysis
Chapter 6 Liver Cancer Diagnostics Market:Screening Type Business Analysis
6.1 Liver Cancer Diagnostics: Type Movement Analysis
6.2 Laboratory Tests
6.2.1 Laboratory Tests market estimates and forecast, 2014 - 2025
6.3 Biomarker Tests
6.3.1 Biomarker Tests market estimates and forecast, 2014 - 2025
6.3.1.1 Oncofetal And Glycoprotein Antigens
6.3.1.1.1 Oncofetal And Glycoprotein Market Estimates And Forecast, 2014 - 2025
6.3.1.2 Enzymes And Isoenzymes
6.3.1.2.1 Enzymes And Isoenzymes Market Estimates And Forecast, 2014 - 2025
6.3.1.3 Growth Factors And Receptors
6.3.1.3.1 Growth Factors And Receptors Market Estimates And Forecast, 2014 - 2025
6.3.1.4 Molecular Markers
6.3.1.4.1 Molecular Markers Market Estimates And Forecast, 2014 - 2025
6.3.1.5 Pathological Biomarkers
6.3.1.5.1 Pathological Biomarkers Market Estimates And Forecast, 2014 - 2025
6.3.2 Blood Tests
6.3.2.1 Blood Tests Market Estimates And Forecast, 2014 - 2025
6.4 Imaging
6.4.1 Imaging Market Estimates And Forecast, 2014 - 2025
6.5 Endoscopy
6.5.1 Endoscopy Market Estimates And Forecast, 2014 - 2025
6.6 Biopsy
6.6.1 Biopsy Market Estimates And Forecast, 2014 - 2025
6.7 Others
6.7.1 Others Market Estimates And Forecast, 2014 - 2025
Chapter 7 Liver Cancer Diagnostics Market Regional Business Analysis
7.1 Liver Cancer Diagnostics Market: Regional Movement Analysis
7.2 North America
7.2.1 North America market estimates and forecast, 2014 - 2025
7.2.2 U.S.
7.2.2.1 U.S. market estimates and forecast, 2014 - 2025
7.2.3 Canada
7.2.3.1 Canada market estimates and forecast, 2014 - 2025
7.3 Europe
7.3.1 Europe market estimates and forecast, 2014 - 2025
7.3.2 Germany
7.3.2.1 Germany market estimates and forecast, 2014 - 2025
7.3.3 U.K.
7.3.3.1 U.K. market estimates and forecast, 2014 - 2025
7.4 Asia Pacific
7.4.1 Asia Pacific market estimates and forecast, 2014 - 2025
7.4.2 Japan
7.4.2.1 Japan market estimates and forecast, 2014 - 2025
7.4.3 China
7.4.3.1 China market estimates and forecast, 2014 - 2025
7.5 Latin America
7.5.1 Brazil
7.5.1.1 Brazil market estimates and forecast, 2014 - 2025
7.5.2 Mexico
7.5.2.1 Mexico market estimates and forecast, 2014 - 2025
7.6 Middle East & Africa
7.6.1 Middle East And Africa market estimates and forecast, 2014 - 2025
7.6.2 Saudi Arabia
7.6.2.1 Saudi Arabia market estimates and forecast, 2014 - 2025
7.6.3 South Africa
7.6.3.1 South Africa market estimates and forecast, 2014 - 2025
Chapter 8 Company Profile
8.1 Abbott Laboratories
8.1.1 Company overview
8.1.2 Financial performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Roche Diagnostics
8.2.1 Company overview
8.2.2 Financial performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Qiagen
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Siemens Healthineers
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Thermo Fischer Scientific Inc.
8.5.1 Company overview
8.5.2 Financial performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Hologic
8.6.1 Company overview
8.6.2 Financial performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Becton, Dickinson and Company
8.7.1 Company overview
8.7.2 Financial performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 Sirtex Medical ltd.
8.8.1 Company overview
8.8.2 Financial performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives
8.9 Koninklijke Philips N.V.
8.9.1 Company overview
8.9.2 Financial performance
8.9.3 Product benchmarking
8.9.4 Strategic initiatives
8.10 Illumina,Inc.
8.10.1 Company overview
8.10.2 Financial performance
8.10.3 Product benchmarking
8.10.4 Strategic initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
Table 3 North America liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 4 North America liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 5 North America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 6 North America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 7 U.S. liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 8 U.S. liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 9 U.S. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 10 U.S. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 11 Canada liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 12 Canada liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 13 Canada liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 14 Canada liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 15 Europe liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
Table 16 Europe liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 17 Europe liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 18 Europe liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 19 Europe liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 20 U.K. liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 21 U.K. liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 22 U.K. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 23 U.K. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 24 Germany liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 25 Germany liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 26 Germany liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 27 Germany liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 28 Asia Pacific liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
Table 29 Asia Pacific liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 30 ASIA Pacific liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 31 Asia Pacific liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 32 Asia Pacific liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 33 China liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 34 China liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 35 China liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 36 China liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 37 Japan liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 38 Japan liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 39 Japan liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 40 Japan liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 41 Latin America liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 42 Latin America liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 43 Latin America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 44 Latin America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 45 Mexico liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 46 Mexico liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 47 Mexico liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 48 Mexico liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 49 Brazil liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 50 Brazi liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 51 Brazil liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 52 Brazil liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 53 MEA liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
Table 54 MEA liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 55 MEA liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 56 MEA liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 57 MEA liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
Table 58 Saudi Arabia liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
Table 59 Saudi Arabia liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
Table 60 Saudi Arabia liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
Table 61 Saudi Arabia liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening) List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Value chain based sizing & forecasting Fig. 6 QFD modelling for market share assessment Fig. 7 Liver cancer diagnostics market snapshot Fig. 8 Liver cancer diagnostics market segmentation Fig. 9 Liver cancer diagnostics market driver impact Fig. 10 Liver cancer diagnostics market driver impact Fig. 11 SWOT Analysis, By Factor (Political & legal Economic and technological) Fig. 12 Porter's five forces analysis Fig. 13 Liver cancer diagnostics: Product outlook and key takeaways Fig. 14 Liver cancer diagnostics: Type movement analysis Fig. 15 Laboratory tests market estimates and forecast, 2014 - 2025 Fig. 16 Biomarker tests market estimates and forecast, 2014 - 2025 Fig. 17 Oncofetal and Glycoprotein market estimates and forecast, 2014 - 2025 Fig. 18 Enzymes and Isoenzymes market estimates and forecast, 2014 - 2025 Fig. 19 Growth factors and receptors market estimates and forecast, 2014 - 2025 Fig. 20 Molecular markers market estimates and forecast, 2014 - 2025 Fig. 21 Pathological Biomarkers market estimates and forecast, 2014 - 2025 Fig. 22 Blood tests market estimates and forecast, 2014 - 2025 Fig. 23 Imaging market estimates and forecast, 2014 - 2025 Fig. 24 Endoscopy markers market estimates and forecast, 2014 - 2025 Fig. 25 Biopsy market estimates and forecast, 2014 - 2025 Fig. 26 Others protein market estimates and forecast, 2014 - 2025 Fig. 27 Liver cancer diagnostics market: Regional outlook and key takeaways Fig. 28 Liver cancer diagnostics market: Regional movement analysis Fig. 29 North America Fig. 30 North America market estimates and forecast, 2014 - 2025 Fig. 31 U.S. market estimates and forecast, 2014 - 2025 Fig. 32 Canada market estimates and forecast, 2014 - 2025 Fig. 33 Europe Fig. 34 Europe market estimates and forecast, 2014 - 2025 Fig. 35 Germany market estimates and forecast, 2014 - 2025 Fig. 36 U.K. market estimates and forecast, 2014 - 2025 Fig. 37 Asia Pacific Fig. 38 Asia pacific market estimates and forecast, 2014 - 2025 Fig. 39 Japan market estimates and forecast, 2014 - 2025 Fig. 40 China. market estimates and forecast, 2014 - 2025 Fig. 41 Australia market estimates and forecast, 2014 - 2025 Fig. 42 Latin America Fig. 43 Latin America market estimates and forecast, 2014 - 2025 Fig. 44 Brazil market estimates and forecast, 2014 - 2025 Fig. 45 Mexico market estimates and forecast, 2014 - 2025 Fig. 46 Middle East & Africa Fig. 47 Middle East & Africa market estimates and forecast, 2014 - 2025 Fig. 48 Saudi Arabia market estimates and forecast, 2014 - 2025 Fig. 49 South Africa market estimates and forecast, 2014 - 2025
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
